Liquid biopsy in neurological diseases
S Malhotra, MCM Miras, A Pappolla, X Montalban… - Cells, 2023 - mdpi.com
The most recent and non-invasive approach for studying early-stage biomarkers is liquid
biopsy. This implies the extraction and analysis of non-solid biological tissues (serum …
biopsy. This implies the extraction and analysis of non-solid biological tissues (serum …
MGMT and whole-genome DNA methylation impacts on diagnosis, prognosis and therapy of glioblastoma multiforme
R Della Monica, M Cuomo, M Buonaiuto… - International Journal of …, 2022 - mdpi.com
Epigenetic changes in DNA methylation contribute to the development of many diseases,
including cancer. In glioblastoma multiforme, the most prevalent primary brain cancer and …
including cancer. In glioblastoma multiforme, the most prevalent primary brain cancer and …
Liquid biopsy in glioblastoma management: from current research to future perspectives
L Gatto, E Franceschi, V Di Nunno, A Tosoni… - The …, 2021 - academic.oup.com
Glioblastoma (GBM) is the most common primary tumor of the central nervous system.
Arising from neuroepithelial glial cells, GBM is characterized by invasive behavior, extensive …
Arising from neuroepithelial glial cells, GBM is characterized by invasive behavior, extensive …
Liquid biopsy and primary brain tumors
RH Eibl, M Schneemann - Cancers, 2021 - mdpi.com
Simple Summary Despite a substantial increase in publications in recent years, liquid biopsy
from blood, cerebrospinal fluid (CSF), and other body fluids is usually not routinely used in …
from blood, cerebrospinal fluid (CSF), and other body fluids is usually not routinely used in …
The involvement of exosomes in glioblastoma development, diagnosis, prognosis, and treatment
Brain tumours are a serious concern among both physicians and patients. The most feared
brain tumour is glioblastoma (GBM) due to its heterogeneous histology, substantial invasive …
brain tumour is glioblastoma (GBM) due to its heterogeneous histology, substantial invasive …
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2–Radiological features and metric markers
C Le Fevre, JM Constans, I Chambrelant… - Critical reviews in …, 2021 - Elsevier
After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …
distinguished from true progression to correctly manage glioblastoma treatment and follow …
Preoperative diagnosis and molecular characterization of gliomas with liquid biopsy and radiogenomics
C Balana, S Castañer, C Carrato, T Moran… - Frontiers in …, 2022 - frontiersin.org
Gliomas are a heterogenous group of central nervous system tumors with different outcomes
and different therapeutic needs. Glioblastoma, the most common subtype in adults, has a …
and different therapeutic needs. Glioblastoma, the most common subtype in adults, has a …
[HTML][HTML] Biomarkers in cerebrospinal fluid for the diagnosis and monitoring of gliomas
D Papadimitrakis, M Perdikakis, AN Gargalionis… - Biomolecules, 2024 - mdpi.com
Gliomas are the most common type of malignant brain tumor and are characterized by a
plethora of heterogeneous molecular alterations. Current treatments require the emergence …
plethora of heterogeneous molecular alterations. Current treatments require the emergence …
Circular RNA sequencing reveals serum exosome circular RNA panel for high-grade astrocytoma diagnosis
P Li, Z Xu, T Liu, Q Liu, H Zhou, S Meng… - Clinical …, 2022 - academic.oup.com
Background Although major advances have been made in the histopathological diagnosis
of high-grade astrocytoma (HGA), methods for effective and noninvasive diagnosis remain …
of high-grade astrocytoma (HGA), methods for effective and noninvasive diagnosis remain …
Human TERT promoter mutations as a prognostic biomarker in glioma
The TERT promoter (pTERT) mutations, C228T and C250T, play a significant role in
malignant transformation by telomerase activation, oncogenesis and immortalisation of cells …
malignant transformation by telomerase activation, oncogenesis and immortalisation of cells …